Although the buying manufacturer may not have AMP for the new NDC-9 to report to the Medicaid Drug Programs system for the Part D rebatable drug's payment amount benchmark period described in 428.202(c)(1) or (c)(2), the buying manufacturer is required by the MDRP to report for the new NDC-9 the base date AMP associated with the dosage form and strength to which the new NDC-9 belongs
Sultan Qaboos Univ Med J
Another laboratory study found that cigarette butts can be a source for heavy metal contamination in water , which may harm local organisms
++ Ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated
Eur Arch Otorhinolaryngol
Eucalyptol, camphor, methyl salicylate, ethyl salicylate, menthol, eugenol, cinnamaldehyde, coumarin, and diphenyl ether were among the nine regularly used flavourings